Friday, September 20, 2024
HomeTagsVerastem Oncology

Verastem Oncology

Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics